Sfoglia per Rivista
Prophylaxis in severe forms of von Willebrand's disease : results from the von Willebrand Disease Prophylaxis Network, (VWD PN)
2013 T.C. Abshire, A.B. Federici, M.T. Alvárez, J. Bowen, M.D. Carcao, J. Cox Gill, N.S. Key, P.A. Kouides, K. Kurnik, A.E. Lail, F.W. Leebeek, M. Makris, P.M. Mannucci, R. Winikoff, E. Berntorp
Prospective controlled studies on prophylaxis : an Italian approach
2003 A. Gringeri
Prospective cost-effectiveness study of regular continuous prophylactic replacement therapy in adults with severe hemophilia A
2008 A. Gringeri, M.S. Monzini, S. von Mackensen, M. Muça-Perja, F. Borghetti, L. Mantovani
Quality of life assessment in clinical practice in haemophilia treatment
2006 A. Gringeri, L. Mantovani, S.V. Mackensen
Quality of life in haemophilia
2008 A. Gringeri, S. von Mackensen
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
2006 L. SCALONE, L. G. MANTOVANI, P. M. MANNUCCI, A. GRINGERI, THE COCIS STUDY INVESTIGATORS
Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients
2002 S. Royal, W. Schramm, E. Berntorp, P. Giangrande, A. Gringeri, C. Ludlam, B. Kroner, T. Szucs, the European haemophilia economics study group
Rare bleeding disorders
2008 F. Peyvandi, M. Cattaneo, A. Inbal, P. De Moerloose, M. Spreafico
Rare bleeding disorders
2012 F. Peyvandi, P.H. Bolton Maggs, A. Batorova, P. De Moerloose
Rare bleeding disorders
2006 F. Peyvandi, R.J. Kaufman, U. Seligsohn, O. Salomon, P.H. Bolton-Maggs, M. Spreafico, M. Menegatti, R. Palla, S. Siboni, P.M. Mannucci
Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency
2014 P. James, O. Salomon, D. Mikovic, F. Peyvandi
Rare coagulation deficiencies
2002 F. Peyvandi, S. Duga, S. Akhavan, P.M. Mannucci
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls
2018 P.M. Mannucci, A. Nobili, E. Marchesini, E. Oliovecchio, L. Cortesi, A. Coppola, E. Santagostino, P. Radossi, G. Castaman, L. Valdrè, C. Santoro, A. Tagliaferri, C. Ettorre, E. Zanon, G. Barillari, I. Cantori, T.M. Caimi, G. Sottilotta, F. Peyvandi, A. Iorio
Real-life experience in switching to new extended half-life products at European haemophilia centres
2019 F. Peyvandi, I. Garagiola, M. Boscarino, A. Ryan, C. Hermans, M. Makris
Recommendations for reporting economic evaluations of haemophilia prophylaxis : a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group
2008 A. Nicholson, K. Berger, R. Bohn, M. Carcao, K. Fischer, A. Gringeri, K. Hoots, L. Mantovani, W. Schramm, B. A. van Hout, A. R. Willan, B. M. Feldman
ReFacto (R)(1) and Advate (R)(2) : a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A
2007 J. Di Paola, M.P. Smith, R. Klamroth, P.M. Mannucci, C. Kollmer, J. Feingold, C. Kessler, H. Pollmann, M. Morfini, C. Udata, C. Rothschild, C. Hermans, R. Janco
Reply to the letter by Iorio
2017 P.M. Mannucci, F. Peyvandi, F.R. Rosendaal
Report on ten new patients with congenital Factor X deficiency and the associated mutations
2008 M. Menegatti, M. Karimi, A. Afrasiabi, F. Peyvandi
Research in haemophilia B - approaching the request for high evidence levels in a rare disease
2015 K. Berger, D. Schopohl, A. Hilger, M. Behr Gross, P. Giangrande, F. Peyvandi, R. Seitz, W. Schramm
Retrospective evaluation of bleeding tendency and simultaneous thrombin and plasmin generation in patients with rare bleeding disorders
2012 M. Van Geffen, M. Menegatti, A. Loof, P. Lap, M. Karimi, B.A. Laros-van Gorkom, P. Brons, W.L. Van Heerde
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile